(Alliance News) - The FTSE 100 struggled for direction on Wednesday, despite progress elsewhere, as investors digested another earnings deluge and looked ahead to the US rate call and earnings from technology titans Meta Platforms and Microsoft. Read More
(Alliance News) - The FTSE 100 made strong progress on Tuesday boosted by results from AstraZeneca and Barclays, but it was gloomy day for investors in Novo Nordisk. Read More
(Alliance News) - The FTSE 100 was higher at midday on Tuesday, boosted by well-received earnings, while peers in Europe were back on the up after struggling at the start of the week as Monday's initial lift from a US-EU trade agreement proved short-lived. Read More
(Alliance News) - Stock prices in London opened mixed on Tuesday, as an earnings boost at AstraZeneca was well received by investors and supported the blue-cap index. Read More
(Alliance News) - AstraZeneca PLC on Tuesday reported better-than-expected second quarter revenue, and raised its dividend, boosted by strong sales from its cancer portfolio. Read More
(Alliance News) - AstraZeneca raised its dividend as drug growth pushed earnings higher, Barclays launched a new buyback programme after profit jumped while Greggs saw profit fall despite higher sales. Read More
(Alliance News) - AstraZeneca PLC on Monday said the US Food & Drug Administration has granted priority review for its immunotherapy drug Imfinzi for some cancer forms. Read More
(Alliance News) - AstraZeneca PLC on Friday said its therapy for the treatment of chronic obstructive pulmonary disease in adults has received a positive opinion from the European Medicines Agency. Read More
(Alliance News) - AstraZeneca PLC on Thursday said its investigational complement C5 inhibitor gefurulimab showed statistically significant results in treating adults with a form of generalised myasthenia gravis, an autoimmune neuromuscular disease. Read More
(Alliance News) - European stocks climbed on Wednesday, boosted by hopes of further progress in trade talks after the US struck a deal with Japan. Read More
(Alliance News) - London stocks are set to open lower on Tuesday, ahead of UK public sector borrowing data and as leadership of the US central bank becomes the focus of public scrutiny. Read More
(Alliance News) - A single, long-lasting jab that offers a "protective bubble" to premature babies from a common virus is set to be rolled out on the NHS in England this autumn. Read More
(Correcting the closing prices for InterContinental Hotels and Diploma, and replacing easyJet with Anglo American for the biggest fallers on the FTSE 100). Read More
(Alliance News) - Stock prices in London closed mostly higher on Thursday, with markets ultimately reassured by US President Donald Trump stating that he did not currently intend to fire Federal Reserve Chair Jerome Powell. Read More
(Alliance News) - AstraZeneca PLC on Wednesday announced that its antibody anselamimab did not achieve statistical significance in the overall patient population, thought it noted a "meaningful improvement" in all-cause mortality in a subgroup of patients. Read More
